| Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals AM Healy, ZA Worku, D Kumar, AM Madi Advanced drug delivery reviews 117, 25-46, 2017 | 363 | 2017 |
| Multidrug co-crystals: towards the development of effective therapeutic hybrids R Thipparaboina, D Kumar, RB Chavan, NR Shastri Drug Discovery Today 21 (3), 481-490, 2016 | 215 | 2016 |
| Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel S Jain, D Kumar, NK Swarnakar, K Thanki Biomaterials 33 (28), 6758-6768, 2012 | 204 | 2012 |
| Co amorphous systems: A product development perspective RB Chavan, R Thipparaboina, D Kumar, NR Shastri International journal of pharmaceutics 515 (1-2), 403-415, 2016 | 179 | 2016 |
| Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth RB Chavan, R Thipparaboina, D Kumar, NR Shastri RSC advances 6 (81), 77569-77576, 2016 | 80 | 2016 |
| Micellar carriers for the delivery of multiple therapeutic agents R Thipparaboina, RB Chavan, D Kumar, S Modugula, NR Shastri Colloids and Surfaces B: Biointerfaces 135, 291-308, 2015 | 79 | 2015 |
| Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: A case study with aceclofenac D Kumar, SVS Chirravuri, NR Shastri International Journal of Pharmaceutics 461 (1-2), 459-468, 2014 | 70 | 2014 |
| Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material … ZA Worku, D Kumar, JV Gomes, Y He, B Glennon, KA Ramisetty, ... International journal of pharmaceutics 531 (1), 191-204, 2017 | 44 | 2017 |
| Crystal engineered albendazole with improved dissolution and material attributes A Thakur, R Thipparaboina, D Kumar, KS Gouthami, NR Shastri CrystEngComm 18 (9), 1489-1494, 2016 | 42 | 2016 |
| Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer DN Kumar, A Chaudhuri, D Dehari, A Shekher, SC Gupta, S Majumdar, ... Life 12 (8), 1143, 2022 | 40 | 2022 |
| Ionic, neutral, and hybrid acid–base crystalline adducts of lamotrigine with improved pharmaceutical performance R Thipparaboina, D Kumar, S Mittapalli, S Balasubramanian, A Nangia, ... Crystal Growth & Design 15 (12), 5816-5826, 2015 | 36 | 2015 |
| Polymeric micelles: A novel drug delivery system for the treatment of breast cancer A Chaudhuri, K Ramesh, DN Kumar, D Dehari, S Singh, D Kumar, ... Journal of Drug Delivery Science and Technology 77, 103886, 2022 | 33 | 2022 |
| Comparison of wet milling and dry milling routes for ibuprofen pharmaceutical crystals and their impact on pharmaceutical and biopharmaceutical properties D Kumar, ZA Worku, Y Gao, VK Kamaraju, B Glennon, RP Babu, ... Powder Technology 330, 228-238, 2018 | 30 | 2018 |
| Emergence of Nanotechnology as a Powerful Cavalry against Triple‐Negative Breast Cancer (TNBC) AC Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, Pradeep Kumar, Pradeep ... Pharmaceuticals 15 (542), 2022 | 25 | 2022 |
| Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol KS Gouthami, D Kumar, R Thipparaboina, RB Chavan, NR Shastri International journal of pharmaceutics 491 (1-2), 26-34, 2015 | 25 | 2015 |
| Effect of surfactant concentration on nifedipine crystal habit and its related pharmaceutical properties D Kumar, R Thipparaboina, SR Modi, AK Bansal, NR Shastri Journal of Crystal Growth 422, 44-51, 2015 | 22 | 2015 |
| Continuous manufacturing and molecular modeling of pharmaceutical amorphous solid dispersions AG Nambiar, M Singh, AR Mali, DR Serrano, R Kumar, AM Healy, ... AAPS PharmSciTech 23 (7), 249, 2022 | 19 | 2022 |
| Effect of HPMC concentration on crystal habit of nifedipine D Kumar, R Thipparaboina, SR Modi, AK Bansal, NR Shastri CrystEngComm 17 (7), 1615-1624, 2015 | 19 | 2015 |
| Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs DK M. R. Dhondale, P Thakor, A. G. Nambiar, M Singh, A.K. Agrawal, N. R. Shastri Pharmaceutics 15 (1), 189, 2023 | 18 | 2023 |
| Cocrystals by design: a rational coformer selection approach for tackling the API problems M Singh, H Barua, VGSS Jyothi, MR Dhondale, AG Nambiar, AK Agrawal, ... Pharmaceutics 15 (4), 1161, 2023 | 17 | 2023 |
Rajesh ThipparaboinaPrincipal Scientist, Formulation R&D, Extrovis Private Limited在 extrovis.com 的电子邮件经过验证
